PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor

References

• Aagaard L, Rossi JJ. (2007). RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev, 59, 75–86.
   PubMed Web of Science ®Google Scholar
• Dykxhoorn DM. (2009). RNA interference as an anticancer therapy: a patent perspective. Expert Opin Ther Pat, 19, 475–491.
   PubMed Web of Science ®Google Scholar
• He S, Zhang D, Cheng F, Gong F, Guo Y. (2009). Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression. Mol Biol Rep, 36, 2153–2163.
   PubMed Web of Science ®Google Scholar
• Christie RJ, Nishiyama N, Kataoka K. (2010). Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies. Endocrinology, 151, 466–473.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. (2011). The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev, 63, 136–151.
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. (2009). Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov, 8, 129–138.
   PubMed Web of Science ®Google Scholar
• HJ, Ishii A, Miyata K, Lee Y, Wu S, Oba M, Nishiyama N, Kataoka K. (2010). Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. J Control Release, 145, 141–148.
   PubMed Web of Science ®Google Scholar
• Miyata K, Oba M, Nakanishi M, Fukushima S, Yamasaki Y, Koyama H, Nishiyama N, Kataoka K. (2008). Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity. J Am Chem Soc, 130, 16287–16294.
   PubMed Web of Science ®Google Scholar
• Owens DE 3rd, Peppas NA. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 307, 93–102.
   PubMed Web of Science ®Google Scholar
• Nomoto T, Matsumoto Y, Miyata K, Oba M, Fukushima S, Nishiyama N, Yamasoba T, Kataoka K. (2011). In situ quantitative monitoring of polyplexes and polyplex micelles in the blood circulation using intravital real-time confocal laser scanning microscopy. J Control Release, 151, 104–109.
   PubMed Web of Science ®Google Scholar
• Itaka K, Kataoka K. (2009). Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm, 71, 475–483.
   PubMed Web of Science ®Google Scholar
• Lee Y, Kataoka K. (2009). Biosignal-sensitive polyion complex micelles for the delivery of biopharmaceuticals. Soft Matter, 5, 3810–3817.
   Web of Science ®Google Scholar
• Soundara Manickam D, Oupický D. (2006). Polyplex gene delivery modulated by redox potential gradients. J Drug Target, 14, 519–526.
   PubMed Web of Science ®Google Scholar
• Park K, Lee MY, Kim KS, Hahn SK. (2010). Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials, 31, 5258–5265.
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, Koyama H, Yamasaki Y, Kataoka K. (2009). Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules, 10, 119–127.
   PubMed Web of Science ®Google Scholar
• Takae S, Miyata K, Oba M, Ishii T, Nishiyama N, Itaka K, Yamasaki Y, Koyama H, Kataoka K. (2008). PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. J Am Chem Soc, 130, 6001–6009.
   PubMed Web of Science ®Google Scholar
• Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, Sternberg P. (2000). Redox state of glutathione in human plasma. Free Radic Biol Med, 28, 625–635.
   PubMed Web of Science ®Google Scholar
• Morré DJ, Morré DM. (2003). Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic Res, 37, 795–808.
   PubMed Web of Science ®Google Scholar
• Balendiran GK, Dabur R, Fraser D. (2004). The role of glutathione in cancer. Cell Biochem Funct, 22, 343–352.
   PubMed Web of Science ®Google Scholar
• Holmes K, Roberts OL, Thomas AM, Cross MJ. (2007). Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal, 19, 2003–2012.
   PubMed Web of Science ®Google Scholar
• Li SD, Chono S, Huang L. (2008). Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Mol Ther, 16, 942–946.
   PubMed Web of Science ®Google Scholar
• Akagi D, Oba M, Koyama H, Nishiyama N, Fukushima S, Miyata T, Nagawa H, Kataoka K. (2007). Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. Gene Ther, 14, 1029–1038.
   PubMed Web of Science ®Google Scholar
• AL-Badri ZM, Som A, Lyon S, Nelson CF, Nüsslein K, Tew GN. (2008). Investigating the effect of increasing charge density on the hemolytic activity of synthetic antimicrobial polymers. Biomacromolecules, 9, 2805–2810.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Nomoto T, Cabral H, Matsumoto Y, Watanabe S, Christie RJ, Miyata K, Oba M, Ogura T, Yamasaki Y, Nishiyama N, Yamasoba T, Kataoka K. (2010). Direct and instantaneous observation of intravenously injected substances using intravital confocal micro-videography. Biomed Opt Express, 1, 1209–1216.
   PubMedGoogle Scholar
• Navarro J, Obrador E, Carretero J, Petschen I, Aviñó J, Perez P, Estrela JM. (1999). Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med, 26, 410–418.
   PubMed Web of Science ®Google Scholar
• Sun W, Davis PB. (2010). Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism. J Control Release, 146, 118–127.
   PubMed Web of Science ®Google Scholar
• Meng F, Hennink WE, Zhong Z. (2009). Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials, 30, 2180–2198.
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. (2008). Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release, 129, 107–116.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV, Woodle MC. (2004). Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res, 32, e149.
   PubMed Web of Science ®Google Scholar